Results 51 to 60 of about 10,152,106 (284)
Internal Medicine, 2016 Inhibitors directed against factor V rarely occur, and the clinical symptoms vary. We herein report the case of a patient who presented with a decreased factor V activity that had decreased to 10 years earlier might have caused the development of a factor V inhibitor.
Daisuke, Hirai +6 more
openaire +3 more sources
High frequency acoustic modes in vitreous Beryllium Fluoride probed by inelastic X-ray scattering
, 2002 Inelastic X-ray Scattering measurements of the dynamics structure factor have bene performed on vitreous Beryllium Fluoride ({\it v-}BeF$_2$) at $T$=297 K in the momentum transfer, $Q$, range $Q$=1.5$\div$10 nm$^{-1}$.
Kastrissios, D. Th. +6 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait +23 more
wiley +1 more source
On the Complexity of Making a Distinguished Vertex Minimum or Maximum Degree by Vertex Deletion [PDF]
, 2014 In this paper, we investigate the approximability of two node deletion problems. Given a vertex weighted graph $G=(V,E)$ and a specified, or "distinguished" vertex $p \in V$, MDD(min) is the problem of finding a minimum weight vertex set $S \subseteq V ...
Devi, N Safina +2 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson +3 more
wiley +1 more source
Circulation, 2003 You may have been tested for the condition known as factor V Leiden (pronounced factor five lye/-den) because you or someone in your family has had a blood clot in one of the deep veins of the body (also called deep vein thrombosis, or DVT) or a blood clot that traveled to the lung (also called a pulmonary embolism, or PE).
Deborah L. Ornstein, Mary Cushman
openaire +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski +9 more
wiley +1 more source
Journal of Research in Medical Sciences, 2015 Background: Factor V G1691A (FV Leiden), FII GA20210, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations are the most common genetic risk factors for thromboembolism in the Western countries.
Mohammad Saadatnia +10 more
doaj +1 more source
3-Factor-criticality in double domination edge critical graphs [PDF]
, 2014 A vertex subset $S$ of a graph $G$ is a double dominating set of $G$ if $|N[v]\cap S|\geq 2$ for each vertex $v$ of $G$, where $N[v]$ is the set of the vertex $v$ and vertices adjacent to $v$.
Shan, Erfang +2 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman +8 more
wiley +1 more source